| 1 |
Kim, H. J., Kim, H., Han, E. S., Park, S. M., Koh, J. Y., Kim, K.
M., Noh, M. S., Kim, J. J. and Lee, C. H. (2008c). Characterizations of sphingosylphosphorylcholine-induced scratching responses in ICR mice using naltrexon, capsaicin, ketotifen and Y-27632. Eur. J. Pharmacol. 583, 92-96.
DOI
|
| 2 |
Folster-Holst, R. and Christophers, E. (2001). Antipruritic therapy in atopic eczema. Hautarzt. 52, 853-861.
DOI
|
| 3 |
Gazerani, P., Pedersen, N. S., Drewes, A. M. and Arendt-
Nielsen, L. (2009). Botulinum toxin type A reduces histamineinduced itch and vasomotor responses in human skin. Br. J. Dermatol. 161, 737-745.
DOI
|
| 4 |
Greaves, M. W. (2007). Recent advances in pathophysiology and current management of itch. Ann. Acad. Med. Singapore 36, 788-792.
|
| 5 |
Gunal, A. I., Ozalp, G., Yoldas, T. K., Gunal, S. Y., Kirciman, E.
and Celiker, H. (2004). Gabapentin therapy for pruritus in haemodialysis patients: a randomized, placebo-controlled, double-blind trial. Nephrol. Dial. Transplant 19, 3137-3139.
DOI
|
| 6 |
Hanifin, J. M., Chan, S. C., Cheng, J. B., Tofte, S. J., Henderson,
W. R. Jr., Kirby, D. S. and Weiner, E. S. (1996). Type 4 phosphodiesterase inhibitors have clinical and in vitro anti-inflammatory effects in atopic dermatitis. J. Invest. Dermatol.
107, 51-56.
DOI
|
| 7 |
Hashimoto, T., Ohata, H. and Momose, K. (2004). Itch-scratch responses induced by lysophosphatidic acid in mice. Pharmacology
72, 51-56.
DOI
|
| 8 |
Hashimoto, T., Ohata, H., Momose, K. and Honda, K. (2005).
Lysophosphatidic acid induces histamine release from mast cells and skin fragments. Pharmacology 75, 13-20.
DOI
|
| 9 |
Heyer, G. R. and Hornstein, O. P. (1999). Recent studies of cutaneous nociception in atopic and non-atopic subjects. J. Dermatol. 26, 77-86.
DOI
|
| 10 |
Fjellner, B. and Hagermark, O. (1979). Pruritus in polycythemia vera: treatment with aspirin and possibility of platelet involvement. Acta. Derm. Venereol. 59, 505-512.
|
| 11 |
Fjellner, B. and Hagermark, O. (1985). Experimental pruritus evoked by platelet activating factor (PAF-acether) in human skin. Acta. Derm. Venereol. 65, 409-412.
|
| 12 |
Davis, M. P., Frandsen, J. L., Walsh, D., Andresen, S. and
Taylor, S. (2003). Mirtazapine for pruritus. J. Pain Symptom. Manage 25, 288-291.
DOI
ScienceOn
|
| 13 |
Dawn, A. G. and Yosipovitch, G. (2006). Butorphanol for treatment of intractable pruritus. J. Am. Acad. Dermatol. 54,
527-531.
DOI
ScienceOn
|
| 14 |
de Oliveira, M. S., Cechim, G., Braganhol, E., Santos, D. G.,
Meurer, L., de Castro, C. G. Jr., Brunetto, A. L., Schwartsmann,
G., Battastini, A. M., Lenz, G. and Roesler, R. (2009).
Anti-proliferative effect of the gastrin-release peptide receptor antagonist RC-3095 plus temozolomide in experimental glioblastoma models. J. Neurooncol. 93, 191-201.
DOI
ScienceOn
|
| 15 |
Dhaka, A., Viswanath, V. and Patapoutian, A. (2006). Trp ion channels and temperature sensation. Annu. Rev. Neurosci.
29, 135-161.
DOI
ScienceOn
|
| 16 |
Dunford, P. J., Williams, K. N., Desai, P. J., Karlsson, L.,
McQueen, D. and Thurmond, R. L. (2007). Histamine H4 receptor antagonists are superior to traditional antihistamines in the attenuation of experimental pruritus. J. Allergy Clin. Immunol. 119, 176-183.
DOI
ScienceOn
|
| 17 |
Ellis, C. N., Drake, L. A., Prendergast, M. M., Abramovits, W.,
Boguniewicz, M., Daniel, C. R., Lebwohl, M., Stevens, S. R.,
Whitaker-Worth, D. L., Cheng, J. W. and Tong, K. B. (2002).
Cost of atopic dermatitis and eczema in the United States. J. Am. Acad. Dermatol. 46, 361-370.
DOI
ScienceOn
|
| 18 |
Figueiredo, A., Ribeiro, C. A., Goncalo, M., Almeida, L., Poiares-Baptista, A. and Teixeira, F. (1990). Mechanism of action of doxepin in the treatment of chronic urticaria. Fundam. Clin. Pharmacol. 4, 147-158.
DOI
ScienceOn
|
| 19 |
Czarnetzki, B. M. and Csato, M. (1989). Comparative studies of human eosinophil migration towards platelet-activating factor and leukotriene B4. Int. Arch. Allergy Appl. Immunol. 88,
191-193.
DOI
|
| 20 |
Fitzsimons, E. J., Dagg, J. H. and McAllister, E. J. (1981).
Pruritus of polycythaemia vera: a place for pizotifen? Br. Med. J. (Clin Res Ed) 283, 277.
|
| 21 |
Daly, B. M. and Shuster, S. (2000). Antipruritic action of thalidomide.
Acta. Derm. Venereol. 80, 24-25.
DOI
ScienceOn
|
| 22 |
Andoh, T., Nishikawa, Y., Yamaguchi-Miyamoto, T., Nojima, H.,
Narumiya, S. and Kuraishi, Y. (2007). Thromboxane A2 induces itch-associated responses through TP receptors in the skin in mice. J. Invest Dermatol. 127, 2042-2047.
DOI
ScienceOn
|
| 23 |
Andoh, T., Saito, A. and Kuraishi, Y. (2009). Leukotriene B(4) mediates sphingosylphosphorylcholine-induced itch-associated responses in mouse skin. J. Invest. Dermatol. 129, 2854-2860.
DOI
ScienceOn
|
| 24 |
Badertscher, K., Bronnimann, M., Karlen, S., Braathen, L. R.
and Yawalkar, N. (2005). Mast cell chymase is increased in chronic atopic dermatitis but not in psoriasis. Arch. Dermatol. Res. 296, 503-506.
DOI
ScienceOn
|
| 25 |
Ballmer-Weber, B. K. and Dummer, R. (2007). Pruritus in frequent skin diseases and therapeutic options. Praxis (Bern1994) 96, 107-111.
DOI
ScienceOn
|
| 26 |
Biro, T., Toth, B. I., Marincsak, R., Dobrosi, N., Geczy, T. and
Paus, R. (2007). TRP channels as novel players in the pathogenesis and therapy of itch. Biochim. Biophys. Acta. 1772, 1004-1021.
DOI
ScienceOn
|
| 27 |
Capella, G. L., Grigerio, E. and Altomare, G. (2001). A randomized trial of leukotriene receptor antagonist montelukast in moderate-to-severe atopic dermatitis of adults. Eur. J. Dermatol. 11, 209-213.
|
| 28 |
Cowden, J. M., Zhang, M., Dunford, P. J. and Thurmond, R. L.
(2010). The histamine H4 receptor mediates inflammation and pruritus in Th2-dependent dermal inflammation. J. Invest. Dermatol. 130, 1023-1033.
DOI
ScienceOn
|
| 29 |
Carucci, J. A., Washenik, K., Weinstein, A., Shupack, J. and
Cohen, D. E. (1998). The leukotriene antagonist zafirlukast as a therapeutic agent for atopic dermatitis. Arch. Dermatol. 134, 785-786.
DOI
ScienceOn
|
| 30 |
Choi, H., Kim, S., Kim, H. J., Kim, K. M., Lee, C. H., Shin, J. H.
and Noh, M. (2010). Sphingosylphosphorylcholine downregulates filaggrin gene transcription through NOX5-based NADPH oxidase and cyclooxygenase-2 in human keratinocytes. Biochem. Pharmacol. 80, 95-103.
DOI
ScienceOn
|
| 31 |
Abeck, D., Andersson, T., Grosshans, E., Jablonska, S., Kragballe,
K., Vahlquist, A., Schmidt, T., Dupuy, P. and Ring, J.
(1997). Topical application of a platelet-activating factor (PAF) antagonist in atopic dermatitis. Acta. Derm. Venereol. 77,
449-451.
|
| 32 |
Andoh, T. and Kuraishi, Y. (2005). Expression of BLT1 leukotriene B4 receptor on the dorsal root ganglion neurons in mice.
Brain Res. Mol. Brain Res. 137, 263-266.
DOI
|
| 33 |
Alenmyr, L., Hogestatt, E. D., Zygmunt, P. M. and Greiff, L.
(2009). TRPV1-mediated itch in seasonal allergic rhinitis.
Allergy 64, 807-810.
DOI
ScienceOn
|
| 34 |
Andoh, T. (2008). Mechanisms of cutaneous itch: new itch mediators and enhancement factors produced by keratinocytes.
Nippon Yakurigaku Zasshi 131, 361-366.
DOI
ScienceOn
|
| 35 |
Andoh, T. and Kuraishi, Y. (1998). Intradermal leukotriene B4, but not prostaglandin E2, induces itch-associated responses in mice. Eur. J. Pharmacol. 353, 93-96.
DOI
ScienceOn
|
| 36 |
Yokoyama, Y., Yokoyama, T., Nagao, Y., Nakagawa, T. and
Magaribuchi, T. (2009). Treatment of epidural morphine induced pruritus with butorphanol. Masui. 58, 178-182.
|
| 37 |
Yosipovitch, G., Szolar, C., Hui, X. Y. and Maibach, H. (1996).
High-potency topical corticosteroid rapidly decreases histamine-induced itch but not thermal sensation and pain in human beings. J. Am. Acad. Dermatol. 35, 118-120.
DOI
|
| 38 |
Yu, B., Shao, Y., Zhang, J., Dong, X. L., Liu, W. L., Yang, H.,
Liu, L., Li, M. H., Yue, C. F., Fang, Z. Y., Zhang, C., Hu, X. P.,
Chen, B. C., Wu, Q., Chen, Y. W., Zhang, W. and Wan, J.
(2010). Polymorphisms in human histamine receptor H4 gene are associated with atopic dermatitis. Br. J. Dermatol.
162, 1038-1043.
DOI
|
| 39 |
Zhang, X., Bao, L. and Ma, G. Q. (2010). Sorting of neuropeptides and neuropeptide receptors into secretory pathways. Prog. Neurobiol. 90, 276-283.
DOI
|
| 40 |
Zylicz, Z., Krajnik, M., Sorge, A. A. and Costantini, M. (2003).
Paroxetine in the treatment of severe non-dermatological pruritus: a randomized, controlled trial. J. Pain. Symptom. Manage 26, 1105-1112.
DOI
|
| 41 |
Yosipovitch, G. and Papoiu, A. D. (2008). What causes itch in atopic dermatitis? Curr. Allergy. Asthma. Rep. 8, 306-311.
DOI
|
| 42 |
Swain, M. G. (2008). Gastrin-releasing peptide and pruritus: more than just scratching the surface. J. Hepatol. 48, 681-683.
DOI
|
| 43 |
Tsujii, K., Andoh, T., Lee, J. B. and Kuraishi, Y. (2008). Activation of proteinase-activated receptors induces itch-associated response through histamine-dependent and -independent pathways in mice. J. Pharmacol. Sci. 108, 385-388.
DOI
|
| 44 |
Taskapan, M. O. (2001). Zileuton and atopic dermatitis. Ann. Allergy Asthma. Immunol. 87, 162-163.
DOI
|
| 45 |
Tigyi, G. and Parrill, A. L. (2003). Molecular mechanisms of lysophosphatidic acid action. Prog. Lipid Res. 42, 498-526.
DOI
|
| 46 |
Tominaga, M., Ozawa, S., Ogawa, H. and Takamori, K. (2007).
A hypothetical mechanism of intraepidermal neurite formation in NC/Nga mice with atopic dermatitis. J. Dermatol. Sci. 46, 199-210.
DOI
|
| 47 |
Weidner, C., Klede, M., Rukwied, R., Lischetzki, G., Neisius, U.,
Skov, P. S., Petersen, L. J. and Schmelz, M. (2000). Acute effects of substance P and calcitonin gene-related peptide in human skin-a microdialysis study. J. Invest. Dermatol. 115,
1015-1020.
DOI
|
| 48 |
Weisshaar, E., Ziethen, B. and Gollnick, H. (1997). Can a serotonin type 3 (5-HT3) receptor antagonist reduce experimentally-induced itch? Inflamm. Res. 46, 412-416.
DOI
|
| 49 |
Woodmansee, D. P. and Simon, R. A. (1999). A pilot study examining the role of zileuton in atopic dermatitis. Ann. Allergy Asthma. Immunol. 83, 548-552.
DOI
|
| 50 |
Yamaura, K., Oda, M., Suwa, E., Suzuki, M., Sato, H. and Ueno,
K. (2009). Expression of histamine H4 receptor in human epidermal tissues and attenuation of experimental pruritus using H4 receptor antagonist. J. Toxicol. Sci. 34, 427-431.
DOI
|
| 51 |
Shelley, W. B., Shelley, E. D. and Talanin, N. Y. (1996). Selfpotentiating allergic contact dermatitis caused by doxepin hydrochloride cream. J. Am. Acad. Dermatol. 34, 143-144.
DOI
|
| 52 |
Steinhoff, M., Neisius, U., Ikoma, A., Fartasch, M., Heyer, G.,
Skov, P. S., Luger, T. A. and Schmelz, M. (2003). Proteinaseactivated receptor-2 mediates itch: a novel pathway for pruritus in human skin. J. Neurosci. 23, 6176-6180.
|
| 53 |
Shimada, S. G., Shimada, K. A. and Collins, J. G. (2006).
Scratching behavior in mice induced by the proteinaseactivated receptor-2 agonist, SLIGRL-NH2. Eur. J. Pharmacol.
530, 281-283.
DOI
|
| 54 |
Sotomayor, S., Munoz-Moreno, L., Carmena, M. J., Schally, A.
V., Sanchez-Chapado, M., Prieto, J. C. and Bajo, A. M.
(2010). Regulation of HER expression and transactivation in human prostate cancer cells by a targeted cytotoxic bombesin analog (AN-215) and a bombesin antagonist (RC-3095). Int. J. Cancer. in press.
|
| 55 |
Stander, S. and Steinhoff, M. (2002). Pathophysiology of pruritus in atopic dermatitis: an overview. Exp. Dermatol. 11, 12-24.
DOI
|
| 56 |
Steinhoff, M., Vergnolle, N., Young, S. H., Tognetto, M.,
Amadesi, S., Ennes, H. S., Trevisani, M., Hollenberg, M. D.,
Wallace, J. L., Caughey, G. H., Mitchell, S. E., Williams, L.
M., Geppetti, P., Mayer, E. A. and Bunnett, N. W. (2000).
Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nat. Med. 6, 151-158.
DOI
|
| 57 |
Summey, B. T., Jr. and Yosipovitch, G. (2005). Pharmacologic advances in the systemic treatment of itch. Dermatol. Ther.
18, 328-332.
DOI
|
| 58 |
Sun, Y. G. and Chen, Z. F. (2007). A gastrin-releasing peptide receptor mediates the itch sensation in the spinal cord. Nature 448, 700-703.
DOI
|
| 59 |
Sun, Y. G., Zhao, Z. Q., Meng, X. L., Yin, J., Liu, X. Y. and Chen,
Z. F. (2009). Cellular basis of itch sensation. Science 325,
1531-1534.
DOI
ScienceOn
|
| 60 |
Miyoshi, M., Sakurai, T. and Kodama, S. (1999). Clinical evaluation of urinary leukotriene E4 levels in children with atopic dermatitis. Arerugi. 48, 1148-1152.
|
| 61 |
Price, M. M., Oskeritzian, C. A., Milstien, S. and Spiegel, S.
(2008). Sphingosine-1-phosphate synthesis and functions in mast cells. Future Lipidol. 3, 665-674.
DOI
|
| 62 |
Neisius, U., Olsson, R., Rukwied, R., Lischetzki, G. and Schmelz,
M. (2002). Prostaglandin E2 induces vasodilation and pruritus, but no protein extravasation in atopic dermatitis and controls. J. Am. Acad. Dermatol. 47, 28-32.
DOI
|
| 63 |
Okuno, T., Iizuka, Y., Okazaki, H., Yokomizo, T., Taguchi, R.
and Shimizu, T. (2008). 12(S)-Hydroxyheptadeca-5Z, 8E, 10E-trienoic acid is a natural ligand for leukotriene B4 receptor 2. J. Exp. Med. 205, 759-766.
DOI
|
| 64 |
Peier, A. M., Reeve, A. J., Andersson, D. A., Moqrich, A.,
Earley, T. J., Hergarden, A. C., Story, G. M., Colley, S.,
Hogenesch, J. B., McIntyre, P., Bevan, S. and Patapoutian,
A. (2002). A heat-sensitive TRP channel expressed in keratinocytes. Science 296, 2046-2049.
DOI
|
| 65 |
Rukwied, R., Lischetzki, G., McGlone, F., Heyer, G. and
Schmelz, M. (2000). Mast cell mediators other than histamine induce pruritus in atopic dermatitis patients: a dermal microdialysis study. Br. J. Dermatol. 142, 1114-1120.
DOI
|
| 66 |
Ryu, S. D., Lee, H. S., Suk, H. Y., Park, C. S. and Choi, O. H.
(2009). Cross-linking of FcepsilonRI causes  mobilization via a sphingosine kinase pathway in a clathrindependent manner. Cell Calcium. 45, 99-108.
DOI
|
| 67 |
Schmelz, M. (2001). A neural pathway for itch. Nat. Neurosci. 4,
9-10.
DOI
|
| 68 |
Schworer, H. and Ramadori, G. (1995). Cholestatic pruritus--pathophysiology and therapy with special reference to treatment with 5-hydroxytryptamine subtype 3 receptor antagonists. Z. Gastroenterol. 33, 265-274.
|
| 69 |
Leung, D. Y. and Soter, N. A. (2001). Cellular and immunologic mechanisms in atopic dermatitis. J. Am. Acad. Dermatol. 44,
S1-S12.
DOI
ScienceOn
|
| 70 |
Kim, H. J., Kim, K. M., Koh, J. Y., Noh, M. S., Park, M. K., Lee,
H. J., Kim, S. Y. and Lee, C. H. (2010). Sphingosylphos-phorylcholine induces degranulation of mast cells in the skin and plasma exudation in the ears of mice. J. Dermatol. Sci.
57, 57-59.
DOI
|
| 71 |
Lewis-Jones, S. (2005). Measuring the burden of atopic eczema in young children and the family unit. J. Invest. Dermatol. 125, viii.
|
| 72 |
Li, W. H., Lee, Y. M., Kim, J. Y., Kang, S., Kim, S., Kim, K. H.,
Park, C. H. and Chung, J. H. (2007). Transient receptor potential vanilloid-1 mediates heat-shock-induced matrix metalloproteinase-1 expression in human epidermal keratinocytes.
J. Invest. Dermatol. 127, 2328-2335.
DOI
|
| 73 |
Liu, Q., Tang, Z., Surdenikova, L., Kim, S., Patel, K. N., Kim, A.,
Ru, F., Guan, Y., Weng, H. J., Geng, Y., Undem, B. J.,
Kollarik, M., Chen, Z. F., Anderson, D. J. and Dong, X.
(2009). Sensory neuron-specific GPCR Mrgprs are itch receptors mediating chloroquine-induced pruritus. Cell 139,
1353-1365.
DOI
|
| 74 |
Lovell, C. R., Burton, P. A., Duncan, E. H. and Burton, J. L.
(1976). Prostaglandins and pruritus. Br. J. Dermatol. 94,
273-275.
DOI
|
| 75 |
Lynde, C. B., Kraft, J. N. and Lynde, C. W. (2008). Novel agents for intractable itch. Skin Therapy Lett. 13, 6-9.
|
| 76 |
Malekzad, F., Arbabi, M., Mohtasham, N., Toosi, P., Jaberian,
M., Mohajer, M., Mohammadi, M. R., Roodsari, M. R. and
Nasiri, S. (2009). Efficacy of oral naltrexone on pruritus in atopic eczema: a double-blind, placebo-controlled study. J. Eur. Acad. Dermatol. Venereol. 23, 948-950.
DOI
|
| 77 |
Jones, E. A. and Bergasa, N. V. (2000). Evolving concepts of the pathogenesis and treatment of the pruritus of cholestasis.
Can. J. Gastroenterol. 14, 33-40.
DOI
|
| 78 |
Metze, D., Reimann, S., Beissert, S. and Luger, T. (1999).
Efficacy and safety of naltrexone, an oral opiate receptor antagonist, in the treatment of pruritus in internal and dermatological diseases. J. Am. Acad. Dermatol. 41, 533-539.
|
| 79 |
Imokawa, G., Takagi, Y., Higuchi, K., Kondo, H. and Yada, Y.
(1999). Sphingosylphosphorylcholine is a potent inducer of intercellular adhesion molecule-1 expression in human keratinocytes. J. Invest. Dermatol. 112, 91-96.
DOI
|
| 80 |
Jiang, J., Kuhara, T., Ueki, R., Zheng, Y., Suto, H., Ikeda, S. and
Ogawa, H. (2007). Inhibitory effects of paroxetine on the development of atopic dermatitis-like lesions in NC/Nga mice. J. Dermatol. Sci. 47, 244-247.
DOI
|
| 81 |
Kim, B. M., Lee, S. H., Shim, W. S. and Oh, U. (2004). Histamineinduced
Ca(2＋) influx via the PLA(2)/lipoxygenase/TRPV1 pathway in rat sensory neurons. Neurosci. Lett. 361,
159-162.
DOI
|
| 82 |
Kim, D. K., Kim, H. J., Kim, H., Koh, J. Y., Kim, K. M., Noh, M.
S., Kim, J. J. and Lee, C. H. (2008a). Involvement of serotonin receptors 5-HT1 and 5-HT2 in 12(S)-HPETEinduced scratching in mice. Eur. J. Pharmacol. 579, 390-394.
DOI
|
| 83 |
Kim, D. K., Kim, H. J., Sung, K. S., Kim, H., Cho, S. A., Kim, K.
M., Lee, C. H. and Kim, J. J. (2007). 12(S)-HPETE induces itch-associated scratchings in mice. Eur. J. Pharmacol. 554,
30-33.
DOI
|
| 84 |
Kim, H. J., Kim, D. K., Kim, H., Koh, J. Y., Kim, K. M., Noh, M.
S., Lee, S., Kim, S., Park, S. H., Kim, J. J., Kim, S. Y. and
Lee, C. H. (2008b). Involvement of the BLT2 receptor in the itch-associated scratching induced by 12-(S)-lipoxygenase products in ICR mice. Br. J. Pharmacol. 154, 1073-1078.
DOI
|
webmaster
